MX366277B - Composiciones de agente activo retinoide particuladas, secas y finas y formulaciones topicas que incluyen las mismas. - Google Patents

Composiciones de agente activo retinoide particuladas, secas y finas y formulaciones topicas que incluyen las mismas.

Info

Publication number
MX366277B
MX366277B MX2015013254A MX2015013254A MX366277B MX 366277 B MX366277 B MX 366277B MX 2015013254 A MX2015013254 A MX 2015013254A MX 2015013254 A MX2015013254 A MX 2015013254A MX 366277 B MX366277 B MX 366277B
Authority
MX
Mexico
Prior art keywords
dry particulate
same
topical formulations
active agent
agent compositions
Prior art date
Application number
MX2015013254A
Other languages
English (en)
Other versions
MX2015013254A (es
Inventor
Xin Chen
Zahra Mansouri
Rodica-Tatiana Canelide
Original Assignee
Laboratory Skin Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51528082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX366277(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratory Skin Care Inc filed Critical Laboratory Skin Care Inc
Publication of MX2015013254A publication Critical patent/MX2015013254A/es
Publication of MX366277B publication Critical patent/MX366277B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Se proporcionan composiciones de retinoide particulado seco y fino adecuadas para usarse en formulaciones tópicas, así como los métodos para hacer las mismas; en las composiciones de retinoides particulado, el agente activo de retinoide está asociado con las partículas, es decir, a través de atrapamiento de las partículas en los poros y/o enlace jónico y/o enlace no covalente de las partículas a la superficie y/o holgadamente asociado con las partículas; también se proporcionan formulaciones tópicas que incluyen las composiciones de retinoide particulado seco de la invención, y métodos para usar las mismas.
MX2015013254A 2013-03-15 2014-03-14 Composiciones de agente activo retinoide particuladas, secas y finas y formulaciones topicas que incluyen las mismas. MX366277B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361798758P 2013-03-15 2013-03-15
US201461938080P 2014-02-10 2014-02-10
PCT/US2014/029673 WO2014145034A1 (en) 2013-03-15 2014-03-14 Fine dry particulate retinoid active agent compositions and topical formulations including the same

Publications (2)

Publication Number Publication Date
MX2015013254A MX2015013254A (es) 2016-04-15
MX366277B true MX366277B (es) 2019-07-04

Family

ID=51528082

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015013254A MX366277B (es) 2013-03-15 2014-03-14 Composiciones de agente activo retinoide particuladas, secas y finas y formulaciones topicas que incluyen las mismas.

Country Status (15)

Country Link
US (5) US20140271879A1 (es)
EP (1) EP2968157B1 (es)
JP (1) JP2016514694A (es)
KR (1) KR20150131285A (es)
CN (2) CN105358135A (es)
AU (1) AU2014233420A1 (es)
BR (1) BR112015023117A2 (es)
CA (1) CA2906838A1 (es)
CL (1) CL2015002688A1 (es)
EA (1) EA201591826A1 (es)
MX (1) MX366277B (es)
MY (1) MY183106A (es)
NZ (1) NZ713342A (es)
SG (1) SG11201507667SA (es)
WO (1) WO2014145034A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX356209B (es) * 2008-09-23 2018-05-18 Laboratory Skin Care Inc Partículas de fosfato de calcio nanoporosas, esféricas, rígidas, uniformes cargadas de agente activo y métodos para su fabricación y su uso.
CA2906838A1 (en) * 2013-03-15 2014-09-18 Laboratory Skin Care, Inc. Fine dry particulate retinoid active agent compositions and topical formulations including the same
CN107108544A (zh) * 2014-11-03 2017-08-29 斯多首饰有限公司 护肤制剂和方案
US11103465B2 (en) 2017-11-22 2021-08-31 Ted's Brain Science, Inc. Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof
CN113181073B (zh) * 2021-04-30 2022-12-23 广州市科能化妆品科研有限公司 一种复合维生素乳液、祛皱精华霜及其制备方法
WO2024045049A1 (en) * 2022-08-31 2024-03-07 L'oreal Composition for caring for keratin materials and mask containing the same
CN115820338A (zh) * 2023-02-22 2023-03-21 中国科学院昆明植物研究所 一种脱臭青刺果油的制备方法及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559149A (en) * 1990-01-29 1996-09-24 Johnson & Johnson Consumer Products, Inc. Skin care compositions containing retinoids
FR2717686B1 (fr) * 1994-03-22 1996-06-28 Fabre Pierre Cosmetique Composition dermo-cosmétologique et procédé de préparation.
US6096324A (en) * 1995-06-13 2000-08-01 Laboratory Skin Care Methods of delivering materials into the skin, and compositions used therein
US5851538A (en) 1995-12-29 1998-12-22 Advanced Polymer Systems, Inc. Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
FR2774907B1 (fr) * 1998-02-19 2000-05-12 Luc Dewandre Nouvelle formulation topique a base de retinaldehyde
US6358517B1 (en) * 1999-10-22 2002-03-19 Unilever Home & Personal Care Usa, Division Of Conopco Cosmetic compositions containing resveratrol and retinoids
DE10233740A1 (de) * 2002-07-24 2004-02-05 Basf Ag Retinoid-haltige Zubereitungen
US20040180091A1 (en) * 2003-03-13 2004-09-16 Chang-Yi Lin Carbonated hydroxyapatite-based microspherical composites for biomedical uses
JP4422681B2 (ja) * 2003-10-15 2010-02-24 株式会社ナノエッグ 多価金属無機塩被覆レチノイン酸ナノ粒子の製造方法および当該製造方法により得られたナノ粒子
KR20100111311A (ko) * 2008-01-30 2010-10-14 티비씨 그룹 컴퍼니 리미티드 피부 외용 조성물 및 미백 화장료
MX356209B (es) * 2008-09-23 2018-05-18 Laboratory Skin Care Inc Partículas de fosfato de calcio nanoporosas, esféricas, rígidas, uniformes cargadas de agente activo y métodos para su fabricación y su uso.
WO2010050980A1 (en) * 2008-10-31 2010-05-06 Laboratory Skin Care, Inc. Topical formulations comprising hydroxyapatite particles for stimulation and maintenance of collagen fibers
KR20180114970A (ko) * 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US9095510B2 (en) * 2009-11-10 2015-08-04 Laboratory Skin Care, Inc. Sunscreen compositions comprising uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
CA2906838A1 (en) * 2013-03-15 2014-09-18 Laboratory Skin Care, Inc. Fine dry particulate retinoid active agent compositions and topical formulations including the same
US11318077B2 (en) * 2017-09-29 2022-05-03 Rodan & Fields, Llc Retinaldehyde containing compositions and methods of use

Also Published As

Publication number Publication date
KR20150131285A (ko) 2015-11-24
EP2968157A4 (en) 2016-12-14
JP2016514694A (ja) 2016-05-23
EA201591826A1 (ru) 2016-01-29
NZ713342A (en) 2020-12-18
AU2014233420A8 (en) 2015-11-26
MY183106A (en) 2021-02-15
WO2014145034A1 (en) 2014-09-18
EP2968157A1 (en) 2016-01-20
SG11201507667SA (en) 2015-10-29
US20160317469A1 (en) 2016-11-03
CN112263549A (zh) 2021-01-26
AU2014233420A1 (en) 2015-11-12
CA2906838A1 (en) 2014-09-18
BR112015023117A2 (pt) 2017-07-18
EP2968157B1 (en) 2023-11-08
US20200222336A1 (en) 2020-07-16
CN105358135A (zh) 2016-02-24
US20180028469A1 (en) 2018-02-01
US20210259991A1 (en) 2021-08-26
US20140271879A1 (en) 2014-09-18
MX2015013254A (es) 2016-04-15
CL2015002688A1 (es) 2016-04-08

Similar Documents

Publication Publication Date Title
MX366277B (es) Composiciones de agente activo retinoide particuladas, secas y finas y formulaciones topicas que incluyen las mismas.
SA517381828B1 (ar) Cftr مركبات، وتركيبات، وطرق لزيادة نشاط
PH12016500642B1 (en) Selective substituted quinoline compounds
UA113440C2 (xx) Сполуки тетрагідропіразолопіримідину
MX2021015825A (es) Formulaciones de anticuerpos estables acuosas.
MX2015009105A (es) Composiciones en solucion solida y su uso en inflamacion cronica.
GB2535876A (en) Absorbent clumping animal litter compositions
IL241823B (en) Preparations containing novyi .c and their uses for the treatment of cancerous tumors
CA2929436C (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
WO2014159669A3 (en) Aptamers that bind to il-6 and their use in treating or diagnosing il-6 mediated conditions
MX2016008150A (es) Formulaciones de berberina y usos de las mismas.
GB2514741A (en) Composition for use as a paint binder
PL2989192T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
MX2015016410A (es) Esteres de acidos oligo-hidroxicarboxilicos y uso de los mismos.
MX2016002930A (es) Moduladores del receptor x hepatico (lxr).
EA201492280A1 (ru) Стабильный состав пексиганана
MY175420A (en) Fine dry particulate resveratrol active agent compositions and topical formulations including the same
FI20136136A (fi) Menetelmä kosmeettisten koostumusten valmistamiseksi, kosmeettiset koostumukset sekä niiden käyttö
ES2426017A2 (es) Microemulsión que comprende colagenasa y usos
IN2013MU03429A (es)
UA78375U (ru) Применение сорбента "силикс" как антисептического и вяжущего средства
IN2013MU02486A (es)
AR100593A1 (es) Composición sinérgica surfactante
MX2016001694A (es) Formulacion de vacuna de sacarido.
EA201500559A1 (ru) Композиция, включающая теанин и экстракт девясила кистевидного

Legal Events

Date Code Title Description
FG Grant or registration